User:Sld101/sandbox

From Wikipedia, the free encyclopedia

Discrimination against people with HIV/AIDS

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people afflicted with HIV/AIDS (PLHIV; people living with HIV/AIDS). Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world.[1]

HIV/AIDS discrimination takes many forms such as blood donation restrictions on at-risk populations, compulsory HIV testing without prior consent, violations of confidentiality within healthcare settings, and targeted violence against persons living with HIV. Although disability laws within many countries prohibit HIV/AIDS discrimination in housing, employment, and access to health/social services, HIV-positive individuals around the world still experience instances of stigma and abuse.[2] Overall, pervasive HIV/AIDS discrimination leads to low turn-out for HIV counseling and testing, identity crises, isolation, loneliness, low self-esteem, and a lack of interest in containing the disease.[3]

Blood Donation Restrictions on At-Risk Populations[edit]

Between 1970 and 1980, more than 20,000 HIV infections were attributed to contaminated blood transfusions. [4]The lack of sensitive blood screening methods for HIV detection prompted the enactment of lifetime bans on blood donations from men who have sex with men (MSM), sex workers, and intravenous drug users, as these population groups were viewed to be at high risk of contracting HIV.[4] At the time, this policy was viewed by health professionals as an emergency measure to prevent the contamination of the general blood supply. Multilateral institutions such as the World Health Organization actively promoted the enactment of lifetime bans in efforts to mitigate transfusion-related HIV infections.[4] This ban was adopted by the United States, as well as several European countries in the 1980’s.[4]

The blood donation ban on MSM and transgender women, in particular, has provoked substantial criticism. Members of the LGBTQ+ community view these laws as discriminatory and homophobic.[5] A significant criticism of the blood donation restrictions is that healthcare workers treat the LGBTQ+ community as a homogenous population that engages in similar sexual practices and behaviors.[5] However, like any other population, MSM vary greatly in the number of sexual partners they have and in their engagement in high-risk sexual behaviors.[5] Overall, the donation ban on MSM and transgender women has further exacerbated growing distrust of the medical system within the LGBTQ+ community, especially given the history of homophobia within the medical profession.[4] As a result of these policies, LGBTQ+ individuals have felt substantial pressure to conceal their sexual orientation from medical providers and healthcare personnel.[4]

Blood banks today utilize advanced serological testing technologies with close to 100% sensitivity and specificity.[4] Currently, the risk of HIV-contaminated blood infection is 1 per 8-to-12 million donations, thus demonstrating the effectiveness of modern HIV screening technologies.[4] Despite these significant laboratory advances, the lifetime blood donation ban on MSM remains in several Western countries.[4] Today, medical organizations such as the American Red Cross and World Health Organization are highly critical of these lifetime bans on men who have sex with men, as the epidemiology of HIV has changed drastically in the last 40 years.[6] In 2015, a mere 27% of novel HIV infections originated from the MSM population.[4] In response to this epidemiological data, public health experts, medical personnel, and blood-banking organizations have called upon country governments to reform these outdated MSM blood donation policies.[6]

Mounting public pressure has prompted countries such as the United States and United Kingdom to reform their MSM blood donation restrictions.[6] In 2015, the United States substituted its lifetime ban for a 12-month deferral since last MSM sexual contact, although indefinite lifetime bans remain in place for sex workers and IV drug users.[7] Despite these small steps in the right direction, the American Red Cross has recommended that the Food and Drug Administration (FDA) further revise its policy by adopting a 3-month deferral period for MSM, as this is the current standard in countries such as Canada and the United Kingdom.[8] Overall, it is estimated that completely lifting the MSM blood donation ban could increase the total blood supply in the United States by 2-4%, which could help save millions of lives.[9] Given the blood supply shortage during the COVID-19 pandemic, blood donation restrictions have recently become the subject of further criticism.[10]

  1. ^ Mahajan, Anish P.; Sayles, Jennifer N.; Patel, Vishal A.; Remien, Robert H.; Ortiz, Daniel; Szekeres, Greg; Coates, Thomas J. (August 2008). "Stigma in the HIV/AIDS epidemic: A review of the literature and recommendations for the way forward". AIDS (London, England). 22 (Suppl 2): S67–S79. doi:10.1097/01.aids.0000327438.13291.62. ISSN 0269-9370. PMC 2835402. PMID 18641472.
  2. ^ "Civil Rights". HIV.gov. 2017-11-10. Retrieved 2018-04-10.
  3. ^ Parker, Richard; Aggleton, Peter (2003-07-01). "HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action". Social Science & Medicine. 57 (1): 13–24. doi:10.1016/S0277-9536(02)00304-0. ISSN 0277-9536. PMID 12753813.
  4. ^ a b c d e f g h i j Karamitros, Georgios; Kitsos, Nikolaos; Karamitrou, Ioanna (2017-06-08). "The ban on blood donation on men who have sex with men: time to rethink and reassess an outdated policy". The Pan African Medical Journal. 27. doi:10.11604/pamj.2017.27.99.12891. ISSN 1937-8688. PMC 5554671. PMID 28819520.
  5. ^ a b c "Ban the Ban: An argument against the 12 month blood donation deferral for men who have sex with men". GLAAD. 2018-11-28. Retrieved 2020-04-06.
  6. ^ a b c Miyashita, Ayako (September 2014). "Effects of Lifting Blood Donation Bans on Men Who Have Sex with Men" (PDF).{{cite web}}: CS1 maint: url-status (link)
  7. ^ Research, Center for Biologics Evaluation and (2019-04-11). "Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products - Questions and Answers". FDA.
  8. ^ "American Red Cross Statement on FDA MSM Deferral Policy". www.redcross.org. Retrieved 2020-04-06.
  9. ^ Miyashita, Ayako (2014). "Effects of Lifting Blood Donation Bans on Men who Have Sex with Men" (PDF). The Williams Institute.{{cite web}}: CS1 maint: url-status (link)
  10. ^ "PAHO warns of potential blood shortages during the COVID-19 pandemic - PAHO/WHO | Pan American Health Organization". www.paho.org (in Spanish). Retrieved 2020-04-27.

Misconceptions about HIV in the United States[edit]

Today, there continues to be significant misconceptions about HIV within the United States. A 2009 study conducted by the Kaiser Family Foundation found that many Americans still lack basic knowledge about HIV [1]. According to the survey, a third of Americans erroneously believed that HIV could be transmitted through sharing a drink or touching a toilet used by an HIV-positive individual [1]. Furthermore, the study reported that 42 percent of American would be uncomfortable with having an HIV-positive roommate, 23 percent would be uncomfortable with an HIV-positive coworker, 50 percent would be uncomfortable with an HIV-positive person preparing their food, and 35 percent would be uncomfortable with their child having an HIV-positive teacher [1]. Many of the respondents who were able to correctly answer questions about HIV transmission still reported similar biased views against HIV-positive individuals; in fact, 85 percent of these respondents that they would feel uncomfortable working with an HIV-positive coworker [1].

These discriminatory views of HIV-positive patients also persist within the medical field. A 2006 study of health professionals in Los Angeles County found that 56 percent of nursing facilities, 47 percent of obstetricians, and 26 percent of plastic surgeons had unlawfully refused to treat an HIV-positive patient, citing concerns of HIV transmission[2]. Overall, this societal stigma and discrimination has exacerbated distrust towards healthcare workers within the HIV-positive population[2]. The health care community therefore has an ethical duty to dispel stereotypes and misconceptions about HIV.

Discriminatory Practices in Health-Care Settings[edit]

Discriminatory practices within the medical field have greatly impacted the health outcomes of HIV-positive individuals.[3] In both low-income and high-income nations, there have been several reported cases of medical providers administering low-quality care or denying care altogether to patients with HIV.[3] In a 2013 study conducted in Thailand, 40.9 percent of health workers reported worrying about touching the clothing and personal belongings of patients with HIV, despite possessing the knowledge that HIV does not spread through such items.[3] In a 2008 study of 90 countries, one in four persons living with HIV reported experiencing some form of discrimination in health-care settings.[3] Furthermore, one in five individuals with HIV reported having been denied medical care.[3] Even more concerning is the impact HIV-related discrimination has had on HIV-positive women. According to the 2008 study, one in three women living with HIV have reported instances of discrimination related to their sexual and reproductive health within a health-care setting.[3]

Another common form of discrimination within healthcare settings is the disclosure of a patient's HIV status without the patient's explicit permission.[3] Within many countries, an HIV-positive status can result in social exclusion, loss of social support, and decreased chances of getting married.[4] Therefore, concerns about potential breaches of confidentiality by health workers pose significant barriers to care for HIV-positive individuals. In a comprehensive study of 31 countries, one in five persons living with HIV reported instances of a health provider disclosing their HIV-positive status without consent.[3]

These discriminatory practices within the medical field have resulted in the delayed initiation of HIV treatment among HIV-positive individuals.[4] In New York City, men who have sex with men, transgender women, and persons of color living with HIV have all reported that stigma among medical providers was a major deterrent from entering or staying in HIV care.[3] A 2011 community-based study found that the most widely reported barrier to care amongst HIV-positive individuals is fear of stigma within healthcare settings.[4] HIV-positive individuals who have experienced significant HIV-related stigma are 2.4 times less likely to present for HIV care.[3] Currently, as many as 20–40 percent of Americans who are HIV-positive do not begin a care regimen within the first six months of diagnosis.[5] Overall, this perpetuation of HIV stigma has been detrimental to the health outcomes of HIV-positive individuals, as patients who begin treatment late in the progression of HIV have a 1.94 times greater risk of mortality in comparison to those who start treatment at the onset of diagnosis.[6] Therefore, delayed HIV treatment due to fears of discrimination can have fatal consequences.[6]

HIV/AIDS Health Disparities in Marginalized Groups[edit]

The U.S. HIV epidemic has drastically evolved over the course of the last 30 years and has been rampantly widespread in socially marginalized and underrepresented communities. The statistics are striking, as most HIV infections afflict sexual minorities and communities of color. For example, in 2009, African Americans accounted for 44% of all new HIV infections while making up only 14% of the U.S. population.[7] Similarly, 78% of HIV infections in Georgia occur among African Americans, while African Americans comprise only 30% of the overall population.[7] Hall et al. (2008) found distinct incidence rates of HIV infection among African Americans (83/100,000 population) and Latinos (29/100,000), specifically when compared to whites (11/100,000). [7]

The single group that is consistently at the greatest risk for HIV infection just happens to form the intersection of sexual orientation and racial background; MSM (men who have sex with men) are the most HIV affected Americans and interestingly enough, African American MSM are at an HIV risk that is six times greater than that of white MSM. [7] Aside from race and sexual orientation, socioeconomic status, education and employment are all equally important factors that can be readily attributed to HIV infection. The CDC reports that HIV rates are highest among groups who are at or below the poverty level; they also found that individuals who are unemployed and/or have less than a high school education are more prone to HIV infection. [7]

In order to help HIV infected persons receive care, the first vital step revolves around HIV testing and early diagnosis. Delayed testing is highly detrimental and leads to an increased risk of HIV transmission. Currently, there are many issues associated with HIV diagnosis and lack of available testing for minorities. A study of 16 US cities found that African Americans are more likely to be tested much later for HIV infection, which places this group at a stark disadvantage for gaining access to proper treatment. [7] This is truly problematic because HIV is only half of the story; a prolonged HIV infection can quickly become an AIDS diagnosis, but all of this can be prevented with early and frequent testing. Approximately 35%-45% of those diagnosed with HIV are believed to also have AIDS at the time of testing. [8] About half of the people diagnosed with HIV do not receive care in any given year, which is ridiculous because they are endangering others and cannot even help themselves. [8] Furthermore, various studies support the notion that groups with lower socioeconomic status and lower education level are unfortunately associated with poorer medication adherence. [9] Conversely, those with HIV who are more privileged and more educated have easy access to quality health insurance and the best medical care, whereas those with HIV that are poor and unemployed have to rely on Medicare for their health care rather than private insurance.

  1. ^ a b c d "2009 Survey of Americans on HIV/AIDS: Summary of Findings on the Domestic Epidemic". The Henry J. Kaiser Family Foundation. 2009-04-02. Retrieved 2020-04-27.
  2. ^ a b Sears, Brad; Ho, Deborah (2006-12-01). "HIV Discrimination in Health Care Services in Los Angeles County: The Results of Three Testing Studies". {{cite journal}}: Cite journal requires |journal= (help)
  3. ^ a b c d e f g h i j "UNAIDS warns that HIV-related stigma and discrimination is preventing people from accessing HIV services". www.unaids.org. Retrieved 2020-05-13.
  4. ^ a b c Pollini, Robin A.; Estela Blanco; Carol Crump; Maria Zuniga (2011). "A community-based study of barriers to HIV care initiation". AIDS Patient Care and STDs. 601-09. 25 (10): 601–609. doi:10.1089/apc.2010.0390. PMC 3183651. PMID 21955175.
  5. ^ Mugavero, MJ (2008). "Improving engagement in HIV care: What can we do?". Top HIV Med. 16 (5): 156–161. PMID 19106431.
  6. ^ a b Panel on Antiretroviral Guidelines for Adults and Adolescents (October 14, 2011). "Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents". Department of Health and Human Services.
  7. ^ a b c d e f Pellowski, Jennifer A.; Kalichman, Seth C.; Matthews, Karen A.; Adler, Nancy (2013). "A pandemic of the poor: social disadvantage and the U.S. HIV epidemic". The American psychologist. 68 (4): 197–209. doi:10.1037/a0032694. ISSN 0003-066X. PMC 3700367. PMID 23688088.
  8. ^ a b Gardner, Edward M.; McLees, Margaret P.; Steiner, John F.; del Rio, Carlos; Burman, William J. (2011-03-15). "The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 52 (6): 793–800. doi:10.1093/cid/ciq243. ISSN 1058-4838. PMC 3106261. PMID 21367734.
  9. ^ Kleeberger, C. A.; Phair, J. P.; Strathdee, S. A.; Detels, R.; Kingsley, L.; Jacobson, L. P. (2001-01-01). "Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study". Journal of Acquired Immune Deficiency Syndromes (1999). 26 (1): 82–92. doi:10.1097/00126334-200101010-00012. ISSN 1525-4135. PMID 11176272.